XCNQ
IAN
Market cap24mUSD
Jun 16, Last price
0.01CAD
1D
0.00%
1Q
-50.00%
Jan 2017
-99.79%
IPO
-99.66%
Name
Ianthus Capital Holdings Inc
Chart & Performance
P/E
—
P/S
0.15
EPS
—
Div Yield, %
—
Shrs. gr., 5y
110.51%
Rev. gr., 5y
16.41%
Revenues
168m
+5.23%
Net income
-8m
L-90.03%
CFO
13m
+315.78%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
iAnthus Capital Holdings, Inc. is a U.S.-based cannabis enterprise that holds licenses for and actively manages cannabis cultivation, processing, and retail dispensary operations. Its diverse product portfolio encompasses both cannabis and cannabidiol (CBD) offerings. For cannabis, these include traditional biomass items like pre-rolls, various infused products such as edibles and topical creams, and a wide array of concentrates and vapeables, specifically live resins, waxes, oils, tinctures, and vape cartridges. The CBD line features topical creams, tinctures, and sprays, alongside a comprehensive range of beauty and skincare solutions, including lotions, haircare items, lip balms, and bath bombs. Beyond direct retail, the company also engages in wholesale distribution of its CBD product selection. Operationally, iAnthus maintains a significant presence, controlling or operating 32 retail dispensaries and 10 cultivation or processing facilities across eight states. Established in 2014, its corporate headquarters are located in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||